Sruthi Adimadhyam, B.Pharm, MS, PhD

Research Scientist II
phone 617-867-4253
email
[email protected]
Primary Divisions and Centers
Division of Therapeutics Research and Infectious Disease Epidemiology (TIDE)

Research Focus

Research Areas: Medical Product Safety and Effectiveness, Public Health

Sruthi Adimadhyam is a Senior Research Scientist at the Harvard Pilgrim Health Care Institute and a Research Associate in the Department of Population Medicine at Harvard Medical School. She holds a PhD and an MS in Pharmacy (focus: pharmacoepidemiology) from the University of Illinois at Chicago.

With over a decade of experience in pharmacoepidemiologic research, Dr. Adimadhyam specializes in the safety and effectiveness of drugs and vaccines using real-world data. She has authored more than 25 peer-reviewed publications and has extensive experience conducting observational post-authorization safety studies using multiple databases in a distributed environment. Her current work involves regulatory-grade drug and vaccine safety assessments in pregnant populations.

Dr. Adimadhyam also teaches evidence-based medicine and pharmacoepidemiologic methods to doctoral and medical students, serves as an invited reviewer for scientific journals, and has presented her research at international conferences.

Featured Publications

See all Sruthi Adimadhyam's Publications

Sequential Safety Surveillance of RSVpreF Vaccination During Pregnancy Early in the Postapproval Period

JAMA Netw Open.

Postmarketing safety surveillance for GSK's AS01E-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in the USA: protocol for a non-interventional postauthorisation safety study

BMJ Open.